RadioMedix
TX - Houston
PharmaceuticalFocus: Radiopharmaceuticals, Imaging Technology
RadioMedix is a life sciences company focused on Radiopharmaceuticals, Imaging Technology.
OncologyNephrologyNuclear MedicineManufacturing
Funding Stage
PUBLIC
Open Jobs
2
Pipeline & Clinical Trials
68Ga-DOTATATE
Neuroendocrine CarcinomaClinical Trials (1)
NCT0187965768Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)
N/AAminoMedixTM for Kidney Protection During Radionuclide Therapy
Radiation NephropathyClinical Trials (1)
NCT05785663AminoMedixTM for Kidney Protection During Radionuclide Therapy
N/A68Ga-PSMA
Prostate CancerClinical Trials (1)
NCT0228213768Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate Cancer
Phase 2Indium-111 pentetreotide
Neuroendocrine TumorsClinical Trials (1)
NCT00442533Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors
Phase 2/364Cu-DOTATATE
Neuroendocrine TumorsClinical Trials (1)
NCT03673943Imaging of Patients With Known or Suspected Somatostatin Receptor Positive Neuroendocrine Tumors Using Cu64-DOTATATE
Phase 3Open Jobs (2)
Interview Prep Quick Facts
Portfolio: 5 clinical trials
Open Roles: 2 active jobs